Back to Stakeholders

The Institute for Psychedelics and Neurotherapeutics (IPN) at UC Davis explores the neuroscience of psychedelics. Under the lead of David Olson, the team conducts high-impact interdisciplinary psychedelic science using modern neurobiology and chemistry tools. Contributions by the group include discovering that psychedelics promote neural plasticity, developing a biosensor for measuring hallucinogenic potential, and designing non-hallucinogenic psychedelic analogues with therapeutic potential.

Academic Research

0 papers

Published Papers

0

Trial Involvement

3

Distinct Focus Topics

0

Latest Publication

Unknown

Quick Facts

Type
academic
HQ
United States
Website
Visit

Sponsored Trials

3